Addae-Konadu Kateena L, Wein Lauren E, Federspiel Jerome J, Hughes Brenna L, Dotters-Katz Sarah
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.
Am J Perinatol. 2024 Feb;41(3):337-342. doi: 10.1055/a-1682-3171. Epub 2021 Oct 28.
Pyelonephritis is the most common nonobstetric cause for hospitalization during pregnancy. The maternal and obstetric complications associated with antepartum pyelonephritis are well described. However, it is not clear whether these risks extend into the postpartum period. The primary objective of this study was to describe the morbidity associated with postpartum pyelonephritis, by comparing the morbidity associated with pyelonephritis in the postpartum period to morbidity seen during pregnancy or delivery.
A retrospective cohort study was performed using the Nationwide Readmissions Database (NRD), an all-payor sample of discharges from approximately 60% of U.S. hospitalizations. Discharges between October 2015 and December 2018 were included. Maternity-associated hospitalizations, diagnosis of pyelonephritis, comorbid conditions, and incidence of severe maternal morbidity were identified using International Classification of Disease-10th Revision (ICD-10) diagnosis and procedure codes. Bivariate statistics, weighted to account for the complex survey methods in the NRD, were used to evaluate the association between antepartum, delivery, and postpartum hospital stays associated with pyelonephritis and maternal morbidity. Weighted regression models were used to evaluate the association between admission timing and maternal outcomes.
A total of 32,850 pyelonephritis admissions were identified, corresponding to a national estimate of 61,837 admissions. Of these, 1,465 (2.4%) were postpartum, 55,056 (89.0%) were antepartum, and 5,317 (8.6%) involved a delivery stay. Rates of severe maternal morbidity were higher in the postpartum group than the antepartum or delivery hospitalization groups (59.5 vs. 12.9 and 15.8%, respectively, < 0.001); when compared with antepartum hospitalizations, the adjusted relative risk for composite severe maternal morbidity for postpartum hospitalizations was 4.68 (95% confidence interval [CI]: 4.33, 5.05). Most of this difference was driven by rates of sepsis (53.2 vs. 11.0 vs. 10.9%).
Though relatively uncommon, postpartum hospitalizations for pyelonephritis are associated with higher rates of severe maternal morbidity, driven by differential rates of sepsis, than are antepartum or delivery-associated hospitalizations.
肾盂肾炎是孕期非产科住院最常见的原因。与产前肾盂肾炎相关的孕产妇和产科并发症已有详尽描述。然而,尚不清楚这些风险是否会延续至产后。本研究的主要目的是通过比较产后肾盂肾炎的发病率与孕期或分娩期的发病率,来描述与产后肾盂肾炎相关的发病情况。
使用全国再入院数据库(NRD)进行了一项回顾性队列研究,该数据库是美国约60%住院病例的全付费者出院样本。纳入了2015年10月至2018年12月期间的出院病例。使用国际疾病分类第十版(ICD - 10)诊断和手术编码确定与产科相关的住院、肾盂肾炎诊断、合并症以及严重孕产妇发病的发生率。采用双变量统计方法(对NRD中复杂的调查方法进行加权)来评估与肾盂肾炎相关的产前、分娩期和产后住院与孕产妇发病之间的关联。使用加权回归模型来评估入院时间与孕产妇结局之间的关联。
共确定了32,850例肾盂肾炎入院病例,全国估计入院病例数为61,837例。其中,1465例(2.4%)为产后,55,056例(89.0%)为产前,5317例(8.6%)涉及分娩住院。产后组严重孕产妇发病率高于产前或分娩住院组(分别为59.5%、12.9%和15.8%,P < 0.001);与产前住院相比,产后住院复合严重孕产妇发病的调整相对风险为4.68(95%置信区间[CI]:4.33,5.05)。这种差异主要由败血症发生率驱动(分别为53.2%、11.0%和10.9%)。
尽管产后肾盂肾炎住院相对少见,但与产前或分娩相关住院相比,由败血症发生率差异导致的严重孕产妇发病率更高。